Abstract
We review the transport systems of the monoamines dopamine, noradrenaline, and serotonin, which are localized in cytoplasmic membranes and the membranes of synaptic vesicles. We present information on the structure of the transporters and the mechanisms of their functioning. Ligands of the transport systems of monoamines include medications and drugs with psychostimulatory action. The most important neurochemical characteristics of ligands of monoamine transport systems is their affinity to transporters and the ability to inhibit reuptake of neuromediators or, in contrast, initiate a reverse current of neurotransmitters. This is the basis of the pharmacological activities of the considered substances.
Similar content being viewed by others
References
Iversen, L., Br. J. Pharmacol., 2006, vol. 147, no. Suppl. 1, pp. S82–S88.
Penmatsa, A. and Gouaux, E., J. Physiol., 2014, vol. 592, Pt 5, pp. 863–869.
Herting, G. and Axelrod, J., Nature, 1961, vol. 192, pp. 172–173.
Herting, G., Axelrod, J., Kopin, I.J., and Whitby, L.G., Nature, 1961, vol. 189, p. 66.
Kristensen, A.S., Andersen, J., Jørgensen, T.N., Sørensen, L., Eriksen, J., Loland, C.J., Strømgaard, K., and Gether, U., Pharmacol. Rev., 2011, vol. 63, no. 3, pp. 585–640.
Wimalasena, K., Med. Res. Rev., 2011, vol. 31, no. 4, pp. 483–519.
Brighina, L., Riva, C., Bertola, F., Saracchi, E., Fermi, S., Goldwurm, S., and Ferrarese, C., Neurobiol. Aging, 2013, vol. 34, no. 6, pp. 1712e9–1712e13.
Lammel, S., Lim, B.K., and Malenka, R.C., Neuropharmacology, 2014, vol. 76, Pt B, pp. 351–359.
Tanda, G., Newman, A.H., and Katz, J.L., Adv. Pharmacol., 2009, vol. 57, pp. 253–289.
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M.M., De Miguel, Z., Ashford, J.W., and Salehi, A., Neurosci. Biobehav. Rev., 2013, vol. 37, no. 8, pp. 1363–1379.
Schmitt, K.C., Rothman, R.B., and Reith, M.E., J. Pharmacol. Exp. Ther., 2013, vol. 346, no. 1, pp. 2–10.
Ramamoorthy, S., Shippenberg, T.S., and Jayanthi, L.D., Pharmacol. Ther., 2011, vol. 129, no. 2, pp. 220–238.
Huot, P., Fox, S.H., and Brotchie, J.M., Parkinsons D., 2015, vol. 2015, Article ID 609428, 71 p.
Reith, M.E., Blough, B.E., Hong, W.C., Jones, K.T., Schmitt, K.C., Baumann, M.H., Partilla, J.S., Rothman, R.B., and Katz, J.L., Drug Alcohol Depend., 2015, vol. 147, pp. 1–19.
Heal, D.J., Gosden, J., and Smith, S.L., Neuropharmacology, 2014, vol. 87, pp. 19–40.
Eriksen, J., Jorgensen, T.N., and Gether, U., J. Neurochem., 2010, vol. 113, no. 1, pp. 27–41.
Focke, P.J., Wang, X., and Larsson, H.P., Structure, 2013, vol. 21, no. 5, pp. 694–705.
Vaughan, R.A. and Foster, J.D., Trends Pharmacol. Sci., 2013, vol. 34, no. 9, pp. 489–496.
Bernstein, A.I., Stout, K.A., and Miller, G.W., Neurochem. Int., 2014, vol. 73, pp. 89–97.
Goldstein, D.S., Adv. Pharmacol, 2013, vol. 68, pp. 235–272.
Eiden, L.E. and Weihe, E., Ann. NY Acad. Sci., 2011, vol. 1216, pp. 86–98.
Schafer, M.K., Weihe, E., and Eiden, L.E., Adv. Pharmacol., 2013, vol. 68, pp. 319–334.
Gu, H., Wall, S.C., and Rudnick, G., J. Biol. Chem., 1994, vol. 269, no. 10, pp. 7124–7130.
Agoston, G.E., Wu, J.H., Izenwasser, S., George, C., Katz, J., Kline, R.H., and Newman, A.H., J. Med. Chem., 1997, vol. 40, no. 26, pp. 4329–4339.
Carroll, F.I., Pawlush, N., Kuhar, M.J., Pollard, G.T., and Howard, J.L., J. Med. Chem., 2004, vol. 47, no. 2, pp. 296–302.
Carroll, F.I., Runyon, S.P., Abraham, P., Navarro, H., Kuhar, M.J., Pollard, G.T., and Howard, J.L., J. Med. Chem., 2004, vol. 47, no. 25, pp. 6401–6409.
Simmler, L.D., Buser, T.A., Donzelli, M., Schramm, Y., Dieu, L.H., Huwyler, J., Chaboz, S., Hoener, M.C., and Liechti, M.E., Br. J. Pharmacol., 2013, vol. 168, no. 2, pp. 458–470.
Pariser, J.J., Partilla, J.S., Dersch, C.M., Ananthan, S., and Rothman, R.B., J. Pharmacol. Exp. Ther., 2008, vol. 326, no. 1, pp. 286–295.
Rothman, R.B., Dersch, C.M., Ananthan, S., and Partilla, J.S., J. Pharmacol. Exp. Ther., 2009, vol. 329, no. 2, pp. 718–728.
Rothman, R.B., Dersch, C.M., Carroll, F.I., and Ananthan, S., Synapse, 2002, vol. 43, no. 4, pp. 268–274.
Simmler, L.D., Rickli, A., Hoener, M.C., and Liechti, M.E., Neuropharmacology, 2014, vol. 79, pp. 152–160.
Eshleman, A.J., Wolfrum, K.M., Hatfield, M.G., Johnson, R.A., Murphy, K.V., and Janowsky, A., Biochem. Pharmacol., 2013, vol. 85, no. 12, pp. 1803–1815.
López-Arnau, R., Martínez-Clemente, J., Pubill, D., Escubedo, E., and Camarasa, J., Br. J. Pharmacol, 2012, vol. 167, no. 2, pp. 407–420.
Carroll, F.I., Blough, B.E., Mascarella, S.W., Navarro, H.A., Eaton, J.B., Lukas, R.J., and Damaj, M.I., J. Med. Chem., 2010, vol. 53, no. 5, pp. 2204–2014.
Hadlock, G.C., Webb, K.M., McFadden, L.M., Chu, P.W., Ellis, J.D., Allen, S.C., Andrenyak, D.M., Vieira-Brock, P.L., German, C.L., Conrad, K.M., Hoonakker, A.J., Gibb, J.W., Wilkins, D.G., Hanson, G.R., and Fleckenstein, A.E., J. Pharmacol. Exp. Ther., 2011, vol. 339, no. 2, pp. 530–536.
Marusich, J.A., Antonazzo, K.R., Wiley, J.L., Blough, B.E., Partilla, J.S., and Baumann, M.H., Neuropharmacology, 2014, vol. 87, pp. 206–213.
Baumann, M.H., Ayestas, M.A., Partilla, J.S., Sink, J.R., Shulgin, A.T., Daley, P.F., Brandt, S.D., Rothman, R.B., Ruoho, A.E., and Cozzi, N.V., Neuropsychopharmacology, 2012, vol. 37, no. 5, pp. 1192–1203.
Baumann, M.H., Clark, R.D., Budzynski, A.G., Partilla, J.S., Blough, B.E., and Rothman, R.B., Neuropsychopharmacology, 2005, vol. 30, no. 3, pp. 550–560.
Rothman, R.B., Dersch, C.M., Ananthan, S., and Partilla, J.S., J. Pharmacol. Exp. Ther., 2009, vol. 329, no. 2, pp. 718–728.
Daberkow, D.P., Brown, H.D., Bunner, K.D., Kraniotis, S.A., Doellman, M.A., Ragozzino, M.E., Garris, P.A., and Roitman, M.F., J. Neurosci., 2013, vol. 33, no. 2, pp. 452–463.
Cameron, K., Kolanos, R., Vekariya, R., De Felice, L., and Glennon, R.A., Psychopharmacology (Berl.), 2013, vol. 227, no. 3, pp. 493–499.
Baumann, M.H., Williams, Z., Zolkowska, D., and Rothman, R.B., Drug Alcohol Depend., 2011, vol. 114, nos. 2–3, pp. 147–152.
Bradbury, S., Bird, J., Colussi-Mas, J., Mueller, M., Ricaurte, G., and Schenk, S., Addict. Biol., 2014, vol. 19, no. 5, pp. 874–884.
Wright, M.J., Angrish, D., Aarde, S.M., Barlow, D.J., Buczynski, M.W., Creehan, K.M., Vandewater, S.A., Parsons, L.H., Houseknecht, K.L., Dickerson, T.J., and Taffe, M.A., PLoS One, 2012, vol. 7, no. 8, Article e44652, 10 p.
Covey, D.P., Roitman, M.F., and Garris, P.A., Trends Neurosci., 2014, vol. 37, no. 4, pp. 200–210.
Di Chiara, G. and Imperato, A., Proc. Natl. Acad. Sci. U. S. A., 1988, vol. 85, no. 14, pp. 5274–5278.
Baumann, M.H., Partilla, J.S., Lehner, K.R., Thorndike, E.B., Hoffman, A.F., Holy, M., Rothman, R.B., Goldberg, S.R., Lupica, C.R., Sitte, H.H., Brandt, S.D., Tella, S.R., Cozzi, N.V., and Schindler, C.W., Neuropsychopharmacology, 2013, vol. 38, no. 4, pp. 552–562.
Partilla, J.S., Dempsey, A.G., Nagpal, A.S., Blough, B.E., Baumann, M.H., and Rothman, R.B., J. Pharmacol. Exp. Ther., 2006, vol. 319, no. 1, pp. 237–246.
Volz, T.J., Hanson, G.R., and Fleckenstein, A.E., J. Neurochem., 2007, vol. 101, no. 4, pp. 883–888.
Yasumoto, S., Tamura, K., Karasawa, J., Hasegawa, R., Ikeda, K., Yamamoto, T., and Yamamoto, H., Neurosci. Let., 2009, vol. 454, no. 3, pp. 229–232.
Dwoskin, L.P. and Crooks, P.A., Biochem. Pharmacol., 2002, vol. 63, no. 2, pp. 89–98.
Neugebauer, N.M., Harrod, S.B., Stairs, D.J., Crooks, P.A., Dwoskin, L.P., and Bardo, M.T., Eur. J. Pharmacol., 2007, vol. 571, no. 1, pp. 33–38.
Nickell, J.R., Krishnamurthy, S., Norrholm, S., Deaciuc, G., Siripurapu, K.B., Zheng, G., Crooks, P.A., and Dwoskin, L.P., J. Pharmacol. Exp. Ther., 2010, vol. 332, no. 2, pp. 612–621.
Hart, N., Rocha, A., Miller, D.K., and Nation, J.R., J. Psychopharmacol., 2010, vol. 24, no. 1, pp. 51–55.
Polston, J.E., Cunningham, C.S., Rodvelt, K.R., and Miller, D.K., Life Sci., 2006, vol. 79, no. 10, pp. 981–990.
Fog, J.U., Khoshbouei, H., Holy, M., Owens, W.A., Vaegter, C.B., Sen, N., Nikandrova, Y., Bowton, E., McMahon, D.G., Colbran, R.J., Daws, L.C., Sitte, H.H., Javitch, J.A., Galli, A., and Gether, U., Neuron, 2006, vol. 51, no. 4, pp. 417–429.
Rickhag, M., Owens, W.A., Winkler, M.T., Strandfelt, K.N., Rathje, M., Sorensen, G., Andresen, B., Madsen, K.L., Jørgensen, T.N., Wörtwein, G., Woldbye, D.P., Sitte, H., Daws, L.C., and Gether, U., J. Biol. Chem., 2013, vol. 288, no. 38, pp. 27534–27544.
Rothman, R.B., Partilla, J.S., Baumann, M.H., Lightfoot-Siordia, C., and Blough, B.E., J. Pharmacol. Exp. Ther., 2012, vol. 341, no. 1, pp. 251–262.
Cosentino, M., Marino, F., Bombelli, R., Ferrari, M., Lecchini, S., and Frigo, G., Life Sci., 1999, vol. 64, no. 11, pp. 975–981.
Li, S.M., Campbell, B.L., and Katz, J.L., J. Pharmacol. Exp. Ther., 2006, vol. 317, no. 3, pp. 1088–1096.
Apparsundaram, S., Stockdale, D.J., Henningsen, R.A., Milla, M.E., and Martin, R.S., J. Pharmacol. Exp. Ther., 2008, vol. 327, no. 3, pp. 982–990.
Torres, G.E., Gainetdinov, R.R., and Caron, M.G., Nat. Rev. Neurosci., 2003, vol. 4, no. 1, pp. 13–25.
Loland, C.J., Desai, R.I., Zou, M.F., Cao, J., Grundt, P., Gerstbrein, K., Sitte, H.H., Newman, A.H., Katz, J.L., and Gether, U., Mol. Pharmacol., 2008, vol. 73, no. 3, pp. 813–823.
Schmitt, K.C. and Reith, M.E., PLoS One, 2011, vol. 6, no. 10, Article e25790, 13 p.
Schmitt, K.C., Zhen, J., Kharkar, P., Mishra, M., Chen, N., Dutta, A.K., and Reith, M.E., J. Neurochem., 2008, vol. 107, no. 4, pp. 928–940.
Ferragud, A., Velázquez-Sánchez, C., and Canales, J.J., Eur. J. Pharmacol., 2014, vol. 731, pp. 73–79.
Reith, M.E., Ali, S., Hashim, A., Sheikh, I.S., Theddu, N., Gaddiraju, N.V., Mehrotra, S., Schmitt, K.C., Murray, T.F., Sershen, H., Unterwald, E.M., and Davis, F.A., J. Pharmacol. Exp. Ther., 2012, vol. 343, no. 2, pp. 413–425.
Chen, N., Zhen, J., and Reith, M.E., J. Neurochem., 2004, vol. 89, no. 4, pp. 853–864.
Reith, M.E., Berfield, J.L., Wang, L.C., Ferrer, J.V., and Javitch, J.A., J. Biol. Chem., 2001, vol. 276, no. 31, pp. 29012–29018.
Desai, R.I., Kopajtic, T.A., Koffarnus, M., Newman, A.H., and Katz, J.L., J. Neurosci., 2005, vol. 25, no. 8, pp. 1889–1893.
Katz, J.L., Agoston, G.E., Alling, K.L., Kline, R.H., Forster, M.J., Woolverton, W.L., Kopajtic, T.A., and Newman, A.H., Psychopharmacology (Berl.), 2001, vol. 154, no. 4, pp. 362–374.
Katz, J.L., Kopajtic, T.A., Agoston, G.E., and Newman, A.H., J. Pharmacol. Exp. Ther., 2004, vol. 309, no. 2, pp. 650–660.
Newman, A.H., Kline, R.H., Allen, A.C., Izenwasser, S., George, C., and Katz, J.L., J. Med. Chem., 1995, vol. 38, no. 20, pp. 3933–3940.
Ferragud, A., Velázquez-Sánchez, C., Hernández-Rabaza, V., Nácher, A., Merino, V., Cardá, M., Murga, J., and Canales, J.J., Psychopharmacology (Berl.), 2009, vol. 207, no. 2, pp. 281–289.
Hiranita, T., Soto, P.L., Newman, A.H., and Katz, J.L., J. Pharmacol. Exp. Ther., 2009, vol. 329, no. 2, pp. 677–686.
Li, L., Hiranita, T., Hayashi, S., Newman, A.H., and Katz, J.L., Psychopharmacology (Berl.), 2013, vol. 225, no. 3, pp. 733–742.
Desai, R.I., Grandy, D.K., Lupica, C.R., and Katz, J.L., J. Pharmacol. Exp. Ther., 2014, vol. 348, no. 1, pp. 106–115.
Velazquez-Sanchez, C., Ferragud, A., Renau-Piqueras, J., and Canales, J.J., Int. J. Neuropsychopharmacol., 2011, vol. 14, no. 5, pp. 655–665.
Velázquez-Sánchez, C., García-Verdugo, J.M., Murga, J., and Canales, J.J., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2013, vol. 44, pp. 73–80.
Hiranita, T., Kohut, S.J., Soto, P.L., Tanda, G., Kopajtic, T.A., and Katz, J.L., J. Pharmacol. Exp. Ther., 2014, vol. 348, no. 1, pp. 174–191.
Li, S.M., Kopajtic, T.A., O’Callaghan, M.J., Agoston, G.E., Cao, J., Newman, A.H., and Katz, J.L., J. Pharmacol. Exp. Ther., 2011, vol. 336, no. 2, pp. 575–585.
Golovko, A.I., Leont’eva, L.V., Basharin, V.A., Golovko, S.I., Ivanov, M.B., Bonitenko, E.Yu., and Barinov, V.A., Narkologiya, 2014, no. 8, pp. 83–93.
Fleckenstein, A.E., Volz, T.J., Riddle, E.L., Gibb, J.W., and Hanson, G.R., Annu. Rev. Pharmacol. Toxicol., 2007, vol. 47, pp. 681–698.
Xie, Z., Westmoreland, S.V., and Miller, G.M., J. Pharmacol. Exp. Ther., 2008, vol. 325, no. 2, pp. 629–640.
Ramamoorthy, S., Samuvel, D.J., Balasubramaniam, A., See, R.E., and Jayanthi, L.D., Biochem. Biophys. Res. Commun., 2010, vol. 391, no. 3, pp. 1517–1521.
Samuvel, D.J., Jayanthi, L.D., Manohar, S., Kaliyaperumal, K., See, R.E., and Ramamoorthy, S., J. Pharmacol. Exp. Ther., 2008, vol. 325, no. 1, pp. 293–301.
Anttila, S.A. and Leinonen, E.V., CNS Drug Rev., 2001, vol. 7, no. 3, pp. 249–264.
Graves, S.M., Rafeyan, R., Watts, J., and Napier, T.C., Pharmacol. Ther., 2012, vol. 136, no. 3, pp. 343–353.
Labasque, M., Meffre, J., Carrat, G., Becamel, C., Bockaert, J., and Marin, P., Mol. Pharmacol., 2010, vol. 78, no. 5, pp. 818–826.
Hajós, M., Fleishaker, J.C., Filipiak-Reisner, J.K., Brown, M.T., and Wong, E.H., CNS Drug Rev., 2004, vol. 10, no. 1, pp. 23–44.
Sepede, G., Corbo, M., Fiori, F., and Martinotti, G., Clin. Ter., 2012, vol. 163, no. 4, e255–e262.
Eyding, D., Lelgemann, M., Grouven, U., Härter, M., Kromp, M., Kaiser, T., Kerekes, M.F., Gerken, M., and Wieseler, B., BMJ, 2010, vol. 341, Article c4737, 14 p.
Berquist, M.D., Peet, M.M., and Baker, L.E., Behav. Pharmacol, 2015, vol. 26, nos. 1–2, pp. 180–183.
Katz, J.L., Izenwasser, S., Kline, R.H., Allen, A.C., and Newman, A.H., J. Pharmacol. Exp. Ther., 1999, vol. 288, no. 1, pp. 302–315.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.I. Golovko, E.Yu. Bonitenko, M.B. Ivanov, V.A. Barinov, E.P. Zatsepin, 2016, published in Neirokhimiya, 2016, Vol. 33, No. 3, pp. 185–196.
Rights and permissions
About this article
Cite this article
Golovko, A.I., Bonitenko, E.Y., Ivanov, M.B. et al. The neurochemical bases of the pharmacological activity of ligands of monoamine-transport systems. Neurochem. J. 10, 173–183 (2016). https://doi.org/10.1134/S1819712416030065
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712416030065